We are 1-(2-Chloro-4-(4-chlorophenyl)butyl)-1H-imidazole CAS:68055-81-2 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
Related News: Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.Tetrakis(butoxyethoxy)silane CAS:18765-38-3 You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs.3,5-difluorobenzonitrilo CAS:64248-63-1 According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.Ácido (E) -3- (5-nitrociclohexen-1-il) prop-2-enoico CAS:899809-64-4 Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%.Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.